These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23970786)

  • 1. ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice.
    Pedram A; Razandi M; Korach KS; Narayanan R; Dalton JT; Levin ER
    Endocrinology; 2013 Nov; 154(11):4352-64. PubMed ID: 23970786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.
    Pedram A; Razandi M; Narayanan R; Dalton JT; McKinsey TA; Levin ER
    Mol Biol Cell; 2013 Dec; 24(24):3805-18. PubMed ID: 24152730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.
    Pedram A; Razandi M; Lubahn D; Liu J; Vannan M; Levin ER
    Endocrinology; 2008 Jul; 149(7):3361-9. PubMed ID: 18372323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents.
    Hoa N; Ge L; Korach KS; Levin ER
    Mol Cell Endocrinol; 2018 Jul; 470():240-250. PubMed ID: 29127073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats.
    Jazbutyte V; Arias-Loza PA; Hu K; Widder J; Govindaraj V; von Poser-Klein C; Bauersachs J; Fritzemeier KH; Hegele-Hartung C; Neyses L; Ertl G; Pelzer T
    Cardiovasc Res; 2008 Mar; 77(4):774-81. PubMed ID: 18056768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-beta prevents cardiac fibrosis.
    Pedram A; Razandi M; O'Mahony F; Lubahn D; Levin ER
    Mol Endocrinol; 2010 Nov; 24(11):2152-65. PubMed ID: 20810711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor beta signals to inhibition of cardiac fibrosis.
    Pedram A; Razandi M; Narayanan R; Levin ER
    Mol Cell Endocrinol; 2016 Oct; 434():57-68. PubMed ID: 27321970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
    Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
    Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Estrogen Receptor β Is Sufficient to Mitigate Cardiac Cell Pathology.
    Ahluwalia A; Hoa N; Moreira D; Aziz D; Singh K; Patel KN; Levin ER
    Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36461668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
    Zhang H; Wu J; Dong H; Khan SA; Chu ML; Tsuda T
    Clin Sci (Lond); 2014 Feb; 126(4):275-88. PubMed ID: 23841699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
    Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
    Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
    Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T
    J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
    Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
    Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
    Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
    PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H- ras deletion protects against angiotensin II-induced arterial hypertension and cardiac remodeling through protein kinase G-Iβ pathway activation.
    Martín-Sánchez P; Luengo A; Griera M; Orea MJ; López-Olañeta M; Chiloeches A; Lara-Pezzi E; de Frutos S; Rodríguez-Puyol M; Calleros L; Rodríguez-Puyol D
    FASEB J; 2018 Feb; 32(2):920-934. PubMed ID: 29054855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats.
    Pelzer T; Jazbutyte V; Hu K; Segerer S; Nahrendorf M; Nordbeck P; Bonz AW; Muck J; Fritzemeier KH; Hegele-Hartung C; Ertl G; Neyses L
    Cardiovasc Res; 2005 Sep; 67(4):604-12. PubMed ID: 15950203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
    Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
    Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.